KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Payables (2016 - 2025)

Edwards Lifesciences has reported Payables over the past 17 years, most recently at $227.5 million for Q4 2025.

  • Quarterly results put Payables at $227.5 million for Q4 2025, up 15.25% from a year ago — trailing twelve months through Dec 2025 was $227.5 million (up 15.25% YoY), and the annual figure for FY2025 was $227.5 million, up 15.25%.
  • Payables for Q4 2025 was $227.5 million at Edwards Lifesciences, up from $165.0 million in the prior quarter.
  • Over the last five years, Payables for EW hit a ceiling of $861.1 million in Q2 2021 and a floor of $139.5 million in Q3 2021.
  • Median Payables over the past 5 years was $186.2 million (2023), compared with a mean of $245.1 million.
  • Biggest five-year swings in Payables: tumbled 83.03% in 2021 and later increased 23.05% in 2023.
  • Edwards Lifesciences' Payables stood at $204.5 million in 2021, then dropped by 1.27% to $201.9 million in 2022, then decreased by 7.58% to $186.6 million in 2023, then rose by 5.79% to $197.4 million in 2024, then increased by 15.25% to $227.5 million in 2025.
  • The last three reported values for Payables were $227.5 million (Q4 2025), $165.0 million (Q3 2025), and $162.1 million (Q2 2025) per Business Quant data.